A Scharfman
Impact in
-
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Inhalation and Respiratory Drug Delivery
- Occupational and environmental lung diseases
Papers in
-
- Cystic Fibrosis Research Advances 5
- Occupational and environmental lung diseases 3
- Genetics 7
- Bacterial Genetics and Biotechnology 3
- Diabetes and associated disorders 2
- Co-authors
- Genevieve Lamblin (10 shared papers)Pascal Roussel (7 shared papers)Edwige Van Brussel (4 shared papers)Nicole Houdret (5 shared papers)Phillipe Roussel (4 shared papers)Reuben Ramphal (3 shared papers)Christophe Carnoy (3 shared papers)Joël Mazurier (1 shared paper)
In The Last Decade
A Scharfman
23 papers receiving 394 citations
Peers
Comparison fields: 5 of 78
- Pulmonary and Respiratory Medicine 160
- Endocrinology 25
- Microbiology 27
- Molecular Biology 208
- Cell Biology 44
Countries citing papers authored by A Scharfman
This map shows the geographic impact of A Scharfman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Scharfman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Scharfman more than expected).
Fields of papers citing papers by A Scharfman
This network shows the impact of papers produced by A Scharfman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Scharfman. The network helps show where A Scharfman may publish in the future.
Co-authors
The 25 scholars most cited alongside A Scharfman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 66 | |
| 2 | 1999 | 58 | |
| 3 | 1986 | 46 | |
| 4 | 1996 | 38 | |
| 5 | 1996 | 33 | |
| 6 | 1991 | 22 | |
| 7 | 1995 | 21 | |
| 8 | 1976 | 20 | |
| 9 | 1983 | 18 | |
| 10 | Selective inhibition of normal murine myelopoiesis "in vitro" by a Hox 2.3 antisense oligodeoxynucleotide. | 1992 | 17 |
| 11 | 1972 | 15 | |
| 12 | 1983 | 14 | |
| 13 | 1981 | 10 | |
| 14 | 1989 | 9 | |
| 15 | 1979 | 8 | |
| 16 | 1991 | 6 | |
| 17 | 1975 | 5 | |
| 18 | Recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) induces human macrophage production of transforming growth factor-alpha. | 1991 | 5 |
| 19 | [Serum alpha macroglobulins of the rabbit]. | 1973 | 3 |
| 20 | 1976 | 2 |
About A Scharfman
A Scharfman is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Endocrinology, Molecular Biology and Nutrition and Dietetics, having authored 23 papers that have together received 420 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (6 papers), Cystic Fibrosis Research Advances (5 papers), Bacterial Genetics and Biotechnology (3 papers), Occupational and environmental lung diseases (3 papers), Enterobacteriaceae and Cronobacter Research (2 papers), Diabetes and associated disorders (2 papers), Bacteriophages and microbial interactions (2 papers) and Legume Nitrogen Fixing Symbiosis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (160 citations), Endocrinology (25 citations), Microbiology (27 citations), Molecular Biology (208 citations) and Cell Biology (44 citations). A Scharfman has collaborated with scholars based in France and China. Frequent co-authors include Genevieve Lamblin, Pascal Roussel, Edwige Van Brussel, Nicole Houdret, Phillipe Roussel, Reuben Ramphal, Christophe Carnoy, Joël Mazurier, Jean‐Marie Beau and Patrick Orson Humbert. Their work appears in journals such as Infection and Immunity, Clinica Chimica Acta, Biochimica et Biophysica Acta (BBA) - General Subjects, Lung and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.